SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders

GlobeNewswire
2025.10.20 12:07
portai
I'm PortAI, I can summarize articles.

TEL AVIV, Israel, Oct. 20, 2025 ( GLOBE NEWSWIRE ) -- SciSparc Ltd. ( Nasdaq: SPRC ) ( "Company" or "SciSparc" ) , a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that ...

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.